Structure-based design of highly selective inhibitors of the CREB binding protein bromodomain
Chemical probes are required for preclinical target validation to interrogate novel biological targets and pathways. Selective inhibitors of the CREB binding protein (CREBBP)/EP300 bromodomains are required to facilitate the elucidation of biology associated with these important epigenetic targets....
Main Authors: | Denny, R, Flick, A, Coe, J, Langille, J, Basak, A, Liu, S, Stock, I, Sahasrabudhe, P, Bonin, P, Hay, D, Brennan, P, Pletcher, M, Jones, L, Chekler, E |
---|---|
Format: | Journal article |
Language: | English |
Published: |
American Chemical Society
2017
|
Similar Items
-
Chemical probes and inhibitors of bromodomains outside the BET family
by: Moustakim, M, et al.
Published: (2016) -
The design and synthesis of 5-and 6-isoxazolylbenzimidazoles as selective inhibitors of the BET bromodomains
by: Hay, D, et al.
Published: (2013) -
Progress in the development and application of small molecule inhibitors of bromodomain-acetyl-lysine interactions.
by: Hewings, D, et al.
Published: (2012) -
Developing small molecule inhibitors of the CREBBP bromodomain-histone interaction
by: Rooney, T, et al.
Published: (2012) -
Effect of BET missense mutations on bromodomain function, inhibitor binding and stability
by: Lori, L, et al.
Published: (2016)